{"id":48666,"date":"2017-06-16T09:40:33","date_gmt":"2017-06-16T04:10:33","guid":{"rendered":"https:\/\/www.legalindia.com\/news\/?p=48666"},"modified":"2017-06-16T09:40:33","modified_gmt":"2017-06-16T04:10:33","slug":"cancer-drug-sc-allows-cipla-withdraw-appeal-roche","status":"publish","type":"post","link":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche","title":{"rendered":"Cancer drug: SC allows Cipla to withdraw appeal against Roche"},"content":{"rendered":"<figure id=\"attachment_47555\" aria-describedby=\"caption-attachment-47555\" style=\"width: 299px\" class=\"wp-caption alignright\"><a href=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?ssl=1\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" data-attachment-id=\"47555\" data-permalink=\"https:\/\/www.legalindia.com\/news\/sc-upholds-life-term-3-killing-gujarat-shiv-sena-leader\/sc-upholds-life-term\" data-orig-file=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&amp;ssl=1\" data-orig-size=\"299,169\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"SC upholds life term\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&amp;ssl=1\" data-large-file=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&amp;ssl=1\" class=\"wp-image-47555 size-full\" src=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?resize=299%2C169&#038;ssl=1\" alt=\"Cancer drug: SC allows Cipla to withdraw appeal against Roche\" width=\"299\" height=\"169\" srcset=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?w=299&amp;ssl=1 299w, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?resize=150%2C85&amp;ssl=1 150w\" sizes=\"auto, (max-width: 299px) 100vw, 299px\" \/><\/a><figcaption id=\"caption-attachment-47555\" class=\"wp-caption-text\">Cancer drug: SC allows Cipla to withdraw appeal against Roche<\/figcaption><\/figure>\n<p>The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.<\/p>\n<p>The apex court was informed that the two companies on May 30 had arrived at a settlement before the Delhi High Court to close the patent dispute between them over the drug erlotinib hydrochloride, manufactured and sold by Roche under the name of Tarceva and Cipla&#8217;s Erlocip.<\/p>\n<p>Cipla had filed a petition challenging the High Court&#8217;s November 27, 2015 order holding that it had infringed Roche&#8217;s patent in a lung cancer drug.<\/p>\n<p>However, after the May 30 settlement, Cipla moved the apex court seeking to withdraw the Special Leave Petition (SLP) filed against the 2015 decision.<\/p>\n<p>Cipla&#8217;s lawyer mentioned the matter before a bench of Justices R K Agrawal and S K Kaul and said both the firms &#8212; Cipla Ltd and F Hoffmann-La Roche Ltd&#8211; have arrived at a settlement over the dispute and now they do not want to pursue the SLP.<\/p>\n<p>The bench, which took up the matter today itself, allowed the application seeking permission to withdraw the petition.<\/p>\n<p>Hours after the court proceeding, a joint statement was issued stating that &#8220;Cipla and Roche\/OSI confirm that they have reached an agreement regarding the ongoing patent disputes relating to the anti-cancer medicine Erlotinib Hydrochloride.<\/p>\n<p>&#8220;As part of the agreement, the companies have ceased all relevant patent litigation on this product and Cipla has acknowledged the validity of the patent rights of Roche, the statement issued by the Swiss Pharma said.<\/p>\n<p>A division bench of the high court had held that Cipla&#8217;s lung cancer medicine, Erlocip, was one polymorphic form of the erlotinib hydrochloride compound, which may exist in several forms, and Roche&#8217;s patent claim was not limited to any one such version.<\/p>\n<p>While Cipla&#8217;s Erlocip, launched in 2008, costs Rs 1,600 per tablet, Roche&#8217;s Tarceva cost Rs 4,800 per tablet. Roche was granted the patent in India for erlotinib hydrochloride on February 23, 2007.<\/p>\n<p>The high court had also imposed a cost of Rs five lakh on Cipla. The bench has remanded the case to the single judge for rendition of Cipla&#8217;s accounts for determination of profits from sale of Erlocip.<\/p>\n<p>The verdict of the division bench had come on the pleas of Cipla and Roche, both of which had challenged the single judge&#8217;s order of September 7, 2012.<\/p>\n<p>The single judge, in his order, had held that Cipla was not infringing Roche&#8217;s patent and had refused to grant any injunction against the Indian company.<\/p>\n<p>The single judge had also refused to revoke the patent of the Swiss company as sought by Cipla.<\/p>\n<p>( Source &#8211; PTI )<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row. The apex court was informed that the two companies on May 30 had arrived at a settlement before the Delhi High Court [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":47555,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1954],"tags":[11351,146,31987,117,80,39718],"class_list":["post-48666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-high-profile-cases","tag-cancer-drug","tag-court","tag-featured","tag-law","tag-legal-news","tag-supreme-court-allows-cipla-to-withdraw-appeal-against-roche"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates<\/title>\n<meta name=\"description\" content=\"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates\" \/>\n<meta property=\"og:description\" content=\"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\" \/>\n<meta property=\"og:site_name\" content=\"Legal News India - Supreme Court &amp; High Court Updates\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LegalindiaCom\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-16T04:10:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"299\" \/>\n\t<meta property=\"og:image:height\" content=\"169\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Legal India Admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Legal India Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\"},\"author\":{\"name\":\"Legal India Admin\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\"},\"headline\":\"Cancer drug: SC allows Cipla to withdraw appeal against Roche\",\"datePublished\":\"2017-06-16T04:10:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\"},\"wordCount\":478,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"keywords\":[\"cancer drug\",\"Court\",\"featured\",\"Law\",\"Legal News\",\"Supreme Court allows Cipla to withdraw appeal against Roche\"],\"articleSection\":[\"High Profile Cases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\",\"name\":\"Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"datePublished\":\"2017-06-16T04:10:33+00:00\",\"description\":\"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/03\\\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1\",\"width\":299,\"height\":169},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"High Profile Cases\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/category\\\/high-profile-cases\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cancer drug: SC allows Cipla to withdraw appeal against Roche\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"name\":\"Legal News India - Supreme Court & High Court Updates\",\"description\":\"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\",\"name\":\"Legal News India: Supreme Court, High Courts & Govt Updates\",\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"Legal News India: Supreme Court, High Courts & Govt Updates\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/LegalindiaCom\\\/\",\"https:\\\/\\\/x.com\\\/Legal_india\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\",\"name\":\"Legal India Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"caption\":\"Legal India Admin\"},\"sameAs\":[\"https:\\\/\\\/www.legalindia.com\",\"https:\\\/\\\/x.com\\\/legaliadmin\"],\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/author\\\/legal-india-admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates","description":"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche","og_locale":"en_US","og_type":"article","og_title":"Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates","og_description":"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","og_url":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche","og_site_name":"Legal News India - Supreme Court &amp; High Court Updates","article_publisher":"https:\/\/www.facebook.com\/LegalindiaCom\/","article_published_time":"2017-06-16T04:10:33+00:00","og_image":[{"width":299,"height":169,"url":"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg","type":"image\/jpeg"}],"author":"Legal India Admin","twitter_misc":{"Written by":"Legal India Admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#article","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche"},"author":{"name":"Legal India Admin","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea"},"headline":"Cancer drug: SC allows Cipla to withdraw appeal against Roche","datePublished":"2017-06-16T04:10:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche"},"wordCount":478,"commentCount":0,"publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","keywords":["cancer drug","Court","featured","Law","Legal News","Supreme Court allows Cipla to withdraw appeal against Roche"],"articleSection":["High Profile Cases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche","url":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche","name":"Cancer drug: SC allows Cipla to withdraw appeal against Roche - Legal News India - Supreme Court &amp; High Court Updates","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","datePublished":"2017-06-16T04:10:33+00:00","description":"The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","breadcrumb":{"@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#primaryimage","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","width":299,"height":169},{"@type":"BreadcrumbList","@id":"https:\/\/www.legalindia.com\/news\/cancer-drug-sc-allows-cipla-withdraw-appeal-roche#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.legalindia.com\/news\/"},{"@type":"ListItem","position":2,"name":"High Profile Cases","item":"https:\/\/www.legalindia.com\/news\/category\/high-profile-cases"},{"@type":"ListItem","position":3,"name":"Cancer drug: SC allows Cipla to withdraw appeal against Roche"}]},{"@type":"WebSite","@id":"https:\/\/www.legalindia.com\/news\/#website","url":"https:\/\/www.legalindia.com\/news\/","name":"Legal News India - Supreme Court & High Court Updates","description":"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"alternateName":"Legal News India for Advocates, Lawyers & Law Students","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.legalindia.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.legalindia.com\/news\/#organization","name":"Legal News India: Supreme Court, High Courts & Govt Updates","alternateName":"Legal News India for Advocates, Lawyers & Law Students","url":"https:\/\/www.legalindia.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"Legal News India: Supreme Court, High Courts & Govt Updates"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LegalindiaCom\/","https:\/\/x.com\/Legal_india"]},{"@type":"Person","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea","name":"Legal India Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","caption":"Legal India Admin"},"sameAs":["https:\/\/www.legalindia.com","https:\/\/x.com\/legaliadmin"],"url":"https:\/\/www.legalindia.com\/news\/author\/legal-india-admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/03\/SC-upholds-life-term.jpg?fit=299%2C169&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":40702,"url":"https:\/\/www.legalindia.com\/news\/drug-patent-war-fm-auction-coal-ordinance-kept-delhi-hc-busy","url_meta":{"origin":48666,"position":0},"title":"Drug patent war, FM auction, coal ordinance kept Delhi HC busy","author":"Legal India News","date":"January 2, 2016","format":false,"excerpt":"The patent war involving domestic and multi-national pharma majors, tussle between the Centre and a private radio channel over FM auctions kept the Delhi High Court\u00a0busy in 2015 during which it also rapped the Centre for its coal auction ordinance by saying that the legislation \"lacked clarity\". The hastily-formulated coal\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2015\/08\/NCDRC.jpg?fit=420%2C239&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":40720,"url":"https:\/\/www.legalindia.com\/news\/drug-patent-war-fm-auction-coal-ordinance-kept-delhi-hc-busy-2","url_meta":{"origin":48666,"position":1},"title":"Drug patent war, FM auction, coal ordinance kept Delhi HC busy","author":"Legal India Admin","date":"January 3, 2016","format":false,"excerpt":"The patent war involving domestic and multi-national pharma majors, tussle between the Centre and a private radio channel over FM auctions kept the Delhi High Court busy in 2015 during which it also rapped the Centre for its coal auction ordinance by saying that the legislation \u201clacked clarity\u201d.The hastily-formulated coal\u2026","rel":"","context":"In &quot;Court, Judiciary &amp; Legal System&quot;","block_context":{"text":"Court, Judiciary &amp; Legal System","link":"https:\/\/www.legalindia.com\/news\/category\/court-judiciary-legal-system"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2016\/01\/DELHI_HIGH_COURT.jpg?fit=636%2C477&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2016\/01\/DELHI_HIGH_COURT.jpg?fit=636%2C477&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2016\/01\/DELHI_HIGH_COURT.jpg?fit=636%2C477&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":27517,"url":"https:\/\/www.legalindia.com\/news\/sc-rejects-plea-of-novartis-for-patent-of-glivec-drug","url_meta":{"origin":48666,"position":2},"title":"SC rejects plea of Novartis for patent of Glivec drug","author":"Legal India Admin","date":"April 2, 2013","format":false,"excerpt":"The\u00a0Supreme Court cleared the decks for Indian drug manufacturing companies to make available life saving medicines to patients in India at a cheaper rate, by coming to the rescue of cancer patients. A bench comprising Justices Aftab Alam and Ranjana Prakash Desai dismissed a petition of Swiss pharma giant Novartis\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":47221,"url":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","url_meta":{"origin":48666,"position":3},"title":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told","author":"Legal India Admin","date":"March 3, 2017","format":false,"excerpt":"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the Drugs Controller General of India (DCGI) has approved it, Delhi High Court said today. \"Once the designated authority has given approval, you cannot\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":23262,"url":"https:\/\/www.legalindia.com\/news\/novartis-tells-apex-court-it-has-right-to-patent-cancer-drug","url_meta":{"origin":48666,"position":4},"title":"Novartis tells apex court it has right to patent cancer drug","author":"Legal India Admin","date":"September 12, 2012","format":false,"excerpt":"The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man. A Bench of Justices Aftab Alam and Ranajan Prakash Desai posed the query to Novartis AG while hearing its plea seeking affirmation of the\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":50931,"url":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","url_meta":{"origin":48666,"position":5},"title":"SC for relook into 349 FDC medicines by drug advisory board","author":"Legal India Admin","date":"December 18, 2017","format":false,"excerpt":"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on which was set aside by the Delhi High Court. The FDC medicines, including well-known brands such as Corex cough syrup and Vicks Action 500 Extra and\u2026","rel":"","context":"In &quot;High Profile Cases&quot;","block_context":{"text":"High Profile Cases","link":"https:\/\/www.legalindia.com\/news\/category\/high-profile-cases"},"img":{"alt_text":"SC for relook into 349 FDC medicines by drug advisory board","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/08\/judiciary.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_shortlink":"https:\/\/wp.me\/p6H5Bf-cEW","jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/48666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/comments?post=48666"}],"version-history":[{"count":0,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/48666\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media\/47555"}],"wp:attachment":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media?parent=48666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/categories?post=48666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/tags?post=48666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}